Showing 1-12 of 1304 results
Pest Control in Outdoor Cannabis Cultivation: Safe Methods to Protect Your Plants
17 hours agoRevista Cáñamo
Open Trial Explores THC and CBD for Restless Legs Syndrome
21 hours agoRevista Cáñamo
International Review Reveals Widespread CBD Labeling Failures Across Global Markets
21 hours agoRevista Cáñamo
Federal Cannabis Reclassification Enters Written Comment Phase Without Decision Date
21 hours agoRevista Cáñamo
Bankrupt Cannabist MSO Closes New Jersey Cultivation Sites, Sells Retailers to Vireo Growth
yesterdayMJBizDaily
Bipartisan Congressional Effort Aims to Regulate and Tax Hemp THC Products
yesterdayMJBizDaily
Massachusetts Adult-Use Marijuana Sales Repeal Advances to November Ballot
yesterdayMJBizDaily
Alabama Weighs State Marijuana Rescheduling Following Federal Move by Trump Administration
yesterdayMarijuana Moment
Something Stinks in Sinaloa: Corruption and Institutional Collapse Exposed
yesterdayRevista Cáñamo
Beyond the Cage: How Environment Shapes Addiction in Lab Rats
yesterdayRevista Cáñamo
Local Cannabis Bans Fragment California's Market Despite Statewide Legalization
yesterdayRevista Cáñamo
Europe Expands Harm Reduction Programs, But Gaps Remain
yesterdayRevista Cáñamo
Pest Control in Outdoor Cannabis Cultivation: Safe Methods to Protect Your Plants
Protecting cannabis plants from insects, fungi, mites, and other pests is essential for maintaining crop health and quality without compromising safety. This guide explores common cannabis plant pests and evidence-based cultivation techniques that prevent infestations while avoiding toxic chemical treatments. Proper integrated pest management (IPM) strategies help outdoor growers maintain healthy plants and maximize yield throughout the growing season. Understanding pest identification and early intervention methods is crucial for cultivators in Puerto Rico's humid tropical climate, where pest pressure is typically higher.
Open Trial Explores THC and CBD for Restless Legs Syndrome
A preliminary open-label trial involving 18 participants showed reduced severity of restless legs syndrome symptoms following treatment with a THC and CBD preparation. However, the absence of placebo control, blinding, and randomization limits the ability to attribute improvements directly to the treatment. The findings represent an early clinical signal that warrants further investigation through more rigorous, controlled studies. Patients interested in cannabinoid therapies should consult healthcare providers before considering any treatment approach.
International Review Reveals Widespread CBD Labeling Failures Across Global Markets
A comprehensive review of 28 studies examining 937 CBD products found that only 31% accurately labeled their cannabidiol content within a ±10% margin of declared amounts. The analysis spanned four continents with concentrated evidence from Europe and North America, highlighting significant quality control issues in the CBD market. These labeling inaccuracies raise serious concerns for patients relying on consistent dosing for therapeutic purposes, as underdosed or overdosed products may compromise treatment efficacy or safety. The findings underscore the critical need for standardized regulatory frameworks and third-party testing to ensure product integrity and consumer protection in the rapidly expanding CBD industry.
Federal Cannabis Reclassification Enters Written Comment Phase Without Decision Date
The DEA's hearing on comprehensive cannabis reclassification has established August 17 as the deadline for final written submissions and transcript corrections. While this deadline helps organize the administrative record, it does not signal an imminent decision or change cannabis's current Schedule I status. This procedural milestone represents an important step in the ongoing federal review process that could ultimately impact medical cannabis access and research opportunities across the United States, including Puerto Rico. Patients and healthcare providers awaiting potential policy changes should recognize that Schedule I classification continues to restrict clinical research and federal recognition of therapeutic applications.
Bankrupt Cannabist MSO Closes New Jersey Cultivation Sites, Sells Retailers to Vireo Growth
The Cannabist Co., a struggling multi-state cannabis operator, is liquidating assets as part of bankruptcy proceedings. Two cultivation facilities in New Jersey will close while three retail locations are being sold to competitor Vireo Growth. This consolidation reflects ongoing financial challenges within the cannabis industry and may impact product availability and pricing in the Northeast region. For patients relying on medical marijuana for therapeutic purposes, such corporate restructuring can affect access to consistent supply and product selection.
Bipartisan Congressional Effort Aims to Regulate and Tax Hemp THC Products
A bipartisan proposal introduced in Congress this week seeks to establish federal regulation and taxation framework for hemp-derived THC products, addressing a legal gray area in the cannabis industry. The legislation comes as the current hemp THC ban approaches implementation, creating uncertainty for businesses and consumers relying on these products. Hemp-derived cannabinoids like delta-8 and delta-10 THC have gained popularity as legal alternatives in states with strict cannabis restrictions, particularly among patients seeking therapeutic benefits. The proposed framework would bring these products under federal oversight similar to traditional cannabis, ensuring quality control and consumer safety standards. This regulatory effort represents a significant shift toward legitimizing and standardizing the hemp THC market while generating tax revenue.
Massachusetts Adult-Use Marijuana Sales Repeal Advances to November Ballot
A ballot measure to repeal Massachusetts' adult-use cannabis market is advancing to the November election, threatening the state's $1.65 billion legal cannabis industry. This development comes as ongoing debates about cannabis legalization continue across the United States. The repeal question could significantly impact patient access to medical cannabis and the broader cannabis regulatory framework in Massachusetts. Voters will decide whether to maintain or eliminate the state's legal adult-use cannabis sales program. This ballot initiative reflects broader national tensions between cannabis legalization advocates and those seeking stricter controls.
Alabama Weighs State Marijuana Rescheduling Following Federal Move by Trump Administration
Alabama's Department of Public Health held a public hearing to consider rescheduling marijuana at the state level, aligning with the Trump administration's federal rescheduling decision. The move recognizes marijuana as having accepted medical uses with relatively low risk, potentially expanding access for patients. Conservative activists voiced objections during the hearing, reflecting ongoing political divisions over cannabis policy. State-level rescheduling could significantly impact medical marijuana patients in Alabama and influence policy discussions across other states. This development demonstrates how federal policy shifts can trigger state-level regulatory reviews and shape the future of cannabis medicine.
Something Stinks in Sinaloa: Corruption and Institutional Collapse Exposed
A damning investigation into Sinaloa's criminal underworld reveals widespread corruption involving police kidnappings, monthly bribes in cash, and institutional collapse. Testimonies from the sons of El Chapo provide unprecedented insight into the narco-economy and systematic corruption that has infiltrated law enforcement and government structures. This exposé highlights the dangerous intersection of organized crime and state institutions, demonstrating how criminal networks have essentially captured key governmental agencies. The revelations underscore the urgent need for institutional reform and anti-corruption measures in affected regions.
Beyond the Cage: How Environment Shapes Addiction in Lab Rats
A groundbreaking study challenges addiction assumptions by showing that Wistar rats given enriched environments—access to social interaction and play—preferred natural behaviors over drug use, unlike isolated rats. This research reveals critical flaws in traditional laboratory models that keep animals in restrictive conditions, demonstrating how environmental deprivation can artificially amplify substance-seeking behavior. The findings highlight the importance of context in addiction studies and question whether lab-based addiction models accurately reflect real-world human vulnerability. Understanding these mechanisms has implications for addiction treatment, mental health approaches, and the ethical design of medical research.
Local Cannabis Bans Fragment California's Market Despite Statewide Legalization
Despite adult cannabis consumption being legal statewide in California, 53% of cities and counties prohibit any cannabis businesses, creating a fragmented regulatory landscape. This municipal authority has resulted in unequal market access, persistent illicit cannabis operations, and enforcement challenges that go beyond simple seizure statistics. The official mapping of cannabis restrictions reveals how local control undermines uniform access to regulated products, affecting patients who rely on consistent, tested, and safe cannabis for medical purposes. For medical cannabis patients in Puerto Rico evaluating their own regulatory framework, California's experience demonstrates the complications that arise when state legalization conflicts with local prohibition. Understanding these market dynamics is essential for developing equitable cannabis policies that balance community concerns with patient access to therapeutic cannabinoids.
Europe Expands Harm Reduction Programs, But Gaps Remain
The European Drugs Agency reports progress in harm reduction initiatives across multiple EU member states, yet warns that coverage remains unequal and inconsistent. Harm reduction programs—which include substance use treatment, supervised consumption facilities, and needle exchange services—are critical public health interventions that reduce overdose deaths and disease transmission. However, the agency notes that varying national indicators make direct comparisons difficult, highlighting the need for standardized data collection. This disparity underscores challenges in implementing consistent health policies across diverse healthcare systems and regulatory frameworks.
Official Portals
Official links from the Puerto Rico Department of Health